The HER2-low tumor category is a newly defined group of breast carcinomas that express low levels of HER2 protein in the membrane of the tumor cells up to HER2 2+ level but show no amplification of the HER2 gene (28, 29). This evidence concerns the gene ERBB2 and breast carcinoma.